Clinical Trial Update: Interleukin-1 Blockade In Recently Decompensated Heart Failure - 2 [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating interleukin-1 blockade in recently decompensated heart failure has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Interleukin-1 blockade (unspecified IL-1 inhibitor)

Snippet

Sponsor: Virginia Commonwealth University | Conditions: Heart Failure, Systolic, Inflammation | Phase 2 | Status: COMPLETED | Results posted: 2025-08-06